Uses & Important Safety Information for HERCEPTIN and HERCEPTIN HYLECTA (trastuzumab and hyaluronidase-oysk)đź”’ SSL Verified
Live Data Status: |E-commerce & Retail
Welcome to the detailed analysis for herceptin.com. This domain is officially recognized as HER2+ Breast & Stomach Cancer Treatment Option | Herceptin® (trastuzumab). According to their official web presence, their primary focus is: "Find information about Herceptin® (trastuzumab), a treatment for HER2+ early and metastatic breast cancer and stomach cancer/GEJ. See full safety & Boxed Warnings for more information.".
Table of Contents
- Tech Stack
- React
- Link Profile
- Internal Pages: 16Outbound Links: 14
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$1,048
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- herceptin.comAvailable
- herceptin.netTaken
- herceptin.orgTaken
- herceptin.ioTaken
- herceptin.coTaken
- herceptin.aiTaken
Content Snippets from herceptin.com
"Herceptin® (trastuzumab) is a prescription medicine designed to treat HER2-positive early breast cancer, HER2-positive metastatic breast cancer, and HER2-positive metastatic stomach cancer. It works by binding to the HER2 protein in the body that promotes the growth of cancer cells. By blocking HER2 activity, Herceptin helps slow or stop cancer cell growth."
"Herceptin is administered as an intravenous infusion in a clinical setting. It is typically given once every three weeks, although this may vary. Your healthcare provider will determine the right dosing schedule based on your medical condition and response to treatment."
"Serious adverse reactions include cardiomyopathy, infusion reactions, pulmonary toxicity, embryo-fetal toxicity, cardiac monitoring, infusion reactions, embryo-fetal toxicity, pulmonary toxicity, and exacerbation of chemotherapy-induced neutropenia. Most common adverse reactions were fever, nausea, vomiting, infusion reactions, diarrhea, infections, increased cough, headache, fatigue, dyspnea, rash, neutropenia, anemia, myalgia, upper respiratory tract infections, thrombocytopenia, nasopharyngitis, and dysgeusia."
"Herceptin is approved for the treatment of adults with early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2-positive and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor / progesterone receptor (ER/PR)-negative or have one high-risk feature.* Herceptin can be used in several different ways:"
Key Topics & Focus Areas for herceptin.com:
Authority Metrics: Score 47/100
Global Reach of Herceptin
Competitor Analysis for .COM Domains
By comparing herceptin.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to herceptin.com.
Frequently Asked Questions
Is herceptin.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of herceptin.com?
As of July 23, 2026, herceptin.com holds an estimated domain authority score of 57/100 based on our VisitRank tracking algorithms.
What are the top alternatives to herceptin.com?
You can find the best alternatives and similar sites to herceptin.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for herceptin.com:
hreceptin.comheceptin.comheerceptin.comharceptin.comhercaptin.comhercepton.comhwrceptin.comhsrceptin.com